Morning Breakouts

Latest KFF Health News Stories

Trump Executive Order Draft On Drug Prices Would Decrease Regulations, Take Steps To Increase Competition

Morning Briefing

CQ Roll Call reports that a draft document indicates that the Trump administration leaning toward a roll back of regulations to foster faster drug approvals and promoting competition and new payment models for federal insurance programs. In other pharmaceutical industry news, Mylan shareholders reject the EpiPen maker’s executive pay policy but re-elect its board.